Recall of Rabies Vaccine (Human Diploid Cell), Imovax Rabies-Aventis Pasteur
DATE RECALL INITIATED:
April 2, 2004
LOT NUMBER / EXPIRATION DATE :
Aventis Pasteur is recalling four lots of Imovax Rabies, Rabies Vaccine (Human Diploid Cell) that were distributed in the U.S. This is a precautionary measure stemming from the discovery through routine testing of a non-inactivated production strain of virus in a single product lot, which was not distributed. As a special safeguard, Aventis Pasteur initiated the voluntary recall in the U.S. and abroad of distributed rabies vaccine lots produced during the same time period. The lots being recalled passed all release tests, including testing to confirm the absence of live virus. The firm is requesting that the use of these lots be immediately discontinued and returned to the manufacturer.